140
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy and Safety of Darunavir/Ritonavir Plus Etravirine Dual Regimen in Antiretroviral Therapy–Experienced Patients: A Multicenter Clinical Experience

, , , , , , , & show all
Pages 140-150 | Published online: 22 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Clotilde Allavena, Christine Katlama, Laurent Cotte, Pierre Marie Roger, Pierre Delobel, Antoine Cheret, Claudine Duvivier, Isabelle Poizot-Martin, Bruno Hoen, André Cabie, Arnaud Cheret, Rima Lahoulou, François Raffi & Pascal Pugliese. (2016) Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients. Infectious Diseases 48:5, pages 392-398.
Read now

Articles from other publishers (8)

Mariana Pereira & Nuno Vale. (2023) A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine. International Journal of Translational Medicine 3:4, pages 461-478.
Crossref
Jesús Enrique Patiño Escarcina, Eduardo Martins NettoCarlos Brites. (2023) Long-term outcomes of highly experienced people with HIV undergoing salvage therapy with raltegravir. Medicine 102:40, pages e35407.
Crossref
Juan Pasquau, Samantha E. de Jesus, Piedad Arazo, María J. Crusells, María J. Ríos, Fernando Lozano, Javier de la Torre, María J. Galindo, Jorge Carmena, Jesús Santos, Carlos Tornero, Guillermo Verdejo, Gloria Samperiz, Zaira Palacios & Carmen Hidalgo-Tenorio. (2019) Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study). BMC Infectious Diseases 19:1.
Crossref
Jordi Navarro, José Ramón Santos, Ana Silva, Joaquin Burgos, Vicenç Falcó, Esteban Ribera, Arkaitz Imaz & Adrian Curran. (2019) Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:4, pages 501-507.
Crossref
Sébastien Landry, Chi-Nan Chen, Nimish Patel, Alice Tseng, Richard G. Lalonde, Denis Thibeault, Steven Sanche & Nancy L. Sheehan. (2018) Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series. Antiviral Research 152, pages 111-116.
Crossref
José Moltó, Adrian Curran, Cristina Miranda, Elizabeth Challenger, José Ramón Santos, Esteban Ribera, Saye Khoo, Marta Valle & Bonaventura Clotet. (2018) Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients. Journal of Antimicrobial Chemotherapy 73:3, pages 732-737.
Crossref
Alessandra Latini, Massimiliano Fabbiani, Vanni Borghi, Gaetana Sterrantino, Alberto Giannetti, Patrizia Lorenzini, Laura Loiacono, Adriana Ammassari, Rita Bellagamba, Manuela Colafigli, Gabriella D’Ettorre, Simona Di Giambenedetto, Andrea Antinori & Mauro Zaccarelli. (2016) Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study. BMC Infectious Diseases 16:1.
Crossref
Carlos Brites, Isabella Nóbrega & Eduardo Martins Netto. (2015) Use of new antiretroviral drugs and classes in Bahia, Brazil: a real life experience on salvage therapy of AIDS patients. The Brazilian Journal of Infectious Diseases 19:5, pages 529-532.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.